Melphalan, prednisone, thalidomide and defibrotide in relapsed/refractory multiple myeloma: results of a multicenter phase I/II trial

BACKGROUND: Defibrotide is a novel orally bioavailable polydisperse oligonucleotide with anti-thrombotic and anti-adhesive effects. In SCID/NOD mice, defibrotide showed activity in human myeloma xenografts. This phase I/II study was conducted to identify the most appropriate dose of defibrotide in c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Palumbo, Antonio, Larocca, Alessandra, Genuardi, Mariella, Kotwica, Katarzyna, Gay, Francesca, Rossi, Davide, Benevolo, Giulia, Magarotto, Valeria, Cavallo, Federica, Bringhen, Sara, Rus, Cecilia, Masini, Luciano, Iacobelli, Massimo, Gaidano, Gianluca, Mitsiades, Constantine, Anderson, Kenneth, Boccadoro, Mario, Richardson, Paul
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2010
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2895039/
https://ncbi.nlm.nih.gov/pubmed/20053869
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.017913
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados